Muscle & Energy + GLP-1/GIP Contains Tirzepatide, B-12, and NAD+, L-Carnitine Compounded oral microdose GLP-1/GIP* (contains Tirzepatide), formulated with NAD+, L-Carnitine, and Vitamin B12 to help support energy, focus, and metabolic performancewithout a primary weight-loss emphasis
Patients should also be aware of potential gallbladder-related symptoms after stopping treatment, particularly if they experienced rapid weight loss while on the medication
N Engl J Med (2021) 384:111324
Tirzepatide (under the brand name Zepbound) was FDA approved for the treatment of obesity in November 2023
However, challenges including high costs exceeding $1000 per month, gastrointestinal side effects, nutritional deficiencies, and low long-term adherence with subsequent weight regain [5] [6] warrant careful consideration
Salerno's office today to schedule a consultation and discover how GLP-1 therapy can make a difference in your life